Back to Search Start Over

Clinical practice guidelines for management of hyperglycaemia in adults with diabetic kidney disease

Authors :
Janaka Karalliedde
Peter Winocour
Tahseen A. Chowdhury
Parijat De
Andrew H. Frankel
Rosa M. Montero
Ana Pokrajac
Debasish Banerjee
Indranil Dasgupta
Damian Fogarty
Adnan Sharif
Mona Wahba
Patrick B. Mark
Sagen Zac‐Varghese
Dipesh C. Patel
Stephen C. Bain
Source :
Diabetic medicine : a journal of the British Diabetic AssociationREFERENCES. 39(4)
Publication Year :
2021

Abstract

A significant percentage of people with diabetes develop chronic kidney disease and diabetes is also a leading cause of end-stage kidney disease (ESKD). The term diabetic kidney disease (DKD) includes both diabetic nephropathy (DN) and diabetes mellitus and chronic kidney disease (DM CKD). DKD is associated with high morbidity and mortality, which are predominantly related to cardiovascular disease. Hyperglycaemia is a modifiable risk factor for cardiovascular complications and progression of DKD. Recent clinical trials of people with DKD have demonstrated improvement in clinical outcomes with sodium glucose co-transporter-2 (SGLT-2) inhibitors. SGLT-2 inhibitors have significantly reduced progression of DKD and onset of ESKD and these reno-protective effects are independent of glucose lowering. At the time of this update Canagliflozin and Dapagliflozin have been approved for delaying the progression of DKD. The Association of British Clinical Diabetologists (ABCD) and UK Kidney Association (UKKA) Diabetic Kidney Disease Clinical Speciality Group have undertaken a literature review and critical appraisal of the available evidence to inform clinical practice guidelines for management of hyperglycaemia in adults with DKD. This 2021 guidance is for the variety of clinicians who treat people with DKD, including GPs and specialists in diabetes, cardiology and nephrology.

Details

ISSN :
14645491
Volume :
39
Issue :
4
Database :
OpenAIRE
Journal :
Diabetic medicine : a journal of the British Diabetic AssociationREFERENCES
Accession number :
edsair.doi.dedup.....4250ca84c06b48df83bc61db6b7defa2